Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - PLURISTEM THERAPEUTICS INC | zk1210981.htm |
| EX-3.1 - EXHBIT 3.1 - PLURISTEM THERAPEUTICS INC | exhibit_3-1.htm |
| EX-10.1 - EXHBIT 10.1 - PLURISTEM THERAPEUTICS INC | exhibit_10-1.htm |
| EX-32.1 - EXHBIT 32.1 - PLURISTEM THERAPEUTICS INC | exhibit_32-1.htm |
| EX-31.1 - EXHBIT 31.1 - PLURISTEM THERAPEUTICS INC | exhibit_31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PLURISTEM THERAPEUTICS INC | Financial_Report.xls |
| EX-31.2 - EXHBIT 31.2 - PLURISTEM THERAPEUTICS INC | exhibit_31-2.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Quarterly Report (the “Report”) of Pluristem Therapeutics Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof, I, Yaky Yany, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: February 9, 2012
|
By: /s/ Yaky Yanay
——————————————
Yaky Yanay
Chief Financial Officer
|